Projects per year
Fingerprint
Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
STAT3 inhibition as a therapeutic strategy against MDS stem cells
Steidl, U. G., Verma, A. K., Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
7/23/19 → 6/30/22
Project: Research project
-
-
Therapeutic targeting of MDS stem cells
Steidl, U. G., Verma, A. K., Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/22
Project: Research project
-
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
1/1/19 → 6/30/20
Project: Research project
-
Publications
-
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Gerds, A. T., Scott, B. L., Greenberg, P., Lin, T. L., Pollyea, D. A., Verma, A., Dail, M., Feng, Y., Green, C., Ma, C., Medeiros, B. C., Yan, M., Yousefi, K. & Donnellan, W., Feb 22 2022, In: Blood Advances. 6, 4, p. 1152-1161 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
Shapiro, L. C., Thakkar, A., Campbell, S. T., Forest, S. K., Pradhan, K., Gonzalez-Lugo, J. D., Quinn, R., Bhagat, T. D., Choudhary, G. S., McCort, M., Sica, R. A., Goldfinger, M., Goel, S., Anampa, J. D., Levitz, D., Fromowitz, A., Shah, A. P., Sklow, C., Alfieri, G., Racine, A. & 4 others, , Jan 10 2022, In: Cancer Cell. 40, 1, p. 3-5 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access14 Scopus citations -
Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave
Lee, M., Quinn, R., Pradhan, K., Fedorov, K., Levitz, D., Fromowitz, A., Thakkar, A., Shapiro, L. C., Kabarriti, R., Ruiz, R. E., Andrews, E. M., Thota, R., Chu, E., Kalnicki, S., Goldstein, Y., Loeb, D., Racine, A., Halmos, B., Mehta, V. & Verma, A., Apr 11 2022, In: Cancer Cell. 40, 4, p. 343-345 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
Komrokji, R. S., Platzbecker, U., Fenaux, P., Zeidan, A. M., Garcia-Manero, G., Mufti, G. J., Santini, V., Díez-Campelo, M., Finelli, C., Jurcic, J. G., Greenberg, P. L., Sekeres, M. A., DeZern, A. E., Savona, M. R., Shetty, J. K., Ito, R., Zhang, G., Ha, X., Backstrom, J. T. & Verma, A., May 2022, In: Leukemia. 36, 5, p. 1432-1435 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss
Morganti, C., Ito, K., Yanase, C., Verma, A., Teruya-Feldstein, J. & Ito, K., May 4 2022, In: EMBO Reports. 23, 5, e54262.Research output: Contribution to journal › Article › peer-review